catechin has been researched along with Adenocarcinoma in 50 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (6.00) | 18.2507 |
| 2000's | 22 (44.00) | 29.6817 |
| 2010's | 23 (46.00) | 24.3611 |
| 2020's | 2 (4.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bianca Xu, G; Chen, H; Chitrakar, B; Gao, Z; Han, X; Lin, X; Sun, Y; Zhang, Z; Zhao, W; Zhou, K; Zhou, Q | 1 |
| Budriesi, R; Chiaino, E; Chiarini, A; Durante, M; Frosini, M; Gotti, R; Marzetti, C; Micucci, M | 1 |
| Ceballos, G; Cordero, P; Gutiérrez-Iglesias, G; Meaney, E; Nájera, N; Palma, I; Ramirez-Sanchez, I; Rubio-Gayosso, I; Varela-Castillo, O; Villarreal, F | 1 |
| He, J; Huang, Y; Li, J; Li, S; Sun, Y; Zhu, Z | 1 |
| Chauhan, CS; Monga, J; Pandit, S; Sharma, M | 1 |
| Chen, YC; Gao, Y; Jia, L; Li, B; Li, W; Tu, Y | 1 |
| Cascante, M; Centelles, JJ; Dudeja, PK; Sánchez-Tena, S; Vizán, P | 1 |
| Adriaens, M; Belshaw, NJ; Connor, CA; Johnson, IT; Pierini, R | 1 |
| Amankwah, E; Choi, J; Chornokur, G; Connors, S; Cornnell, H; Engelman, RW; Hashim, AI; Kim, SJ; Kumar, N; Park, HY; Park, JY; Rincon, M; Tsai, YY | 1 |
| Avello, M; García, A; Parada, V; Pastene, E; Ruiz, A | 1 |
| Khan, N; Mukhtar, H | 1 |
| Fang, Y; Hu, F; Wang, Y; Wei, F; Wu, B; Xiong, B | 1 |
| Lioutikova, E; Manthey, J; Wang, H; Yang, MQ; Yang, W; Yoshigoe, K; Zhou, H | 1 |
| Bettuzzi, S; Caporali, A; Corti, A; Davalli, P; Enkemann, S; Eschrich, S; Lee, A; McCarthy, S; Scaltriti, M; Sung, J; Yeatman, TJ | 1 |
| Belshaw, NJ; Guyot, S; Johnson, IT; Kroon, PA; Pierini, R | 1 |
| Belshaw, NJ; Guyot, S; Ivory, K; Johnson, IT; Kroon, PA; Pierini, R | 1 |
| Bresalier, RS; Krishnan, K; Liu, K; Song, S | 1 |
| Bettuzzi, S; Rizzi, F | 1 |
| Adhami, VM; Khan, N; Mukhtar, H | 1 |
| Ahn, SG; Kim, SA; Park, JH; Yoon, JH | 1 |
| Asif Siddiqui, F; Islam, N; Naim, M | 1 |
| Jin, XF; Liu, Q; Ran, ZH; Tong, JL; Xiao, SD; Xu, Q; Xu, XT; Yang, CH | 1 |
| Brandt, R; Falk, W; Hoffmann, J; Junker, H; Multhoff, G; Radons, J; Schmieder, A; Venz, S | 1 |
| Arcari, M; Astancolle, S; Azzali, G; Bettuzzi, S; Caldara, GF; Corti, A; Davalli, P; Davoli, S; Rizzi, F; Silva, A; Vitale, M | 1 |
| Chitcholtan, K; Dann, JM; Evans, JJ; Guilford, P; Harris, G; Lewis, LK; Nagase, J; Sykes, PH; Welkamp, AA; Zwerus, R | 1 |
| Falk, W; Härdtner, C; Multhoff, G; Radons, J | 1 |
| Blancafort, A; Cufí, S; Haro, D; Marrero, PF; Oliveras, G; Puig, T; Relat, J | 1 |
| Chandra, V; Dwivedi, A; Fatima, I; Manohar, M; Sankhwar, PL; Saxena, R | 1 |
| Kim, MR; Kim, SO | 1 |
| Furukawa, F; Hirose, M; Imazawa, T; Nakamura, H; Natsume, M; Nishikawa, A; Osakabe, N; Yamagishi, M | 1 |
| Stein, J; Turchanowa, L; Wolter, F | 1 |
| Chen, C; Hebbar, V; Hu, R; Kong, AN; Owuor, ED; Shen, G | 1 |
| Agarwal, MK; Agarwal, ML; Ahmad, N; Gupta, S; Hastak, K; Mukhtar, H | 1 |
| Hitsuda, Y; Igishi, T; Kodani, M; Matsumoto, S; Nakanishi, H; Shigeoka, Y; Shimizu, E; Yasuda, K | 1 |
| Albini, A; Calabrese, F; Dell'Aica, I; Donà, M; Garbisa, S; Morini, M; Pezzato, E; Sartor, L | 1 |
| Hara, K; Iwasaka, T; Nakao, Y; Noguchi, M; Uchiyama, M; Watanabe, S; Yokoyama, M | 1 |
| Benghuzzi, H; May, M; Norwood, A; Tan, M; Tucci, M | 1 |
| Adhami, VM; Kweon, MH; Lee, JS; Mukhtar, H | 1 |
| Hao, X; Liao, J; Lu, G; Reuhl, KR; Yang, CS; Yang, G | 1 |
| Benghuzzi, H; Norwood, AA; Tucci, M | 1 |
| Andrews, LG; Berletch, JB; Katiyar, SK; Liu, C; Love, WK; Tollefsbol, TO | 1 |
| Eltoum, IA; Harper, CE; Lamartiniere, CA; Patel, BB; Wang, J | 1 |
| Iwasaka, T; Nakao, Y; Noguchi, M; Yamasaki, F; Yokoyama, M; Ysunaga, M | 1 |
| Maheshwari, RK; Passi, N; Thangapazham, RL | 1 |
| Tachibana, H; Umeda, D; Yamada, K; Yano, S | 1 |
| Fujiki, H; Inagake, M; Kitao, Y; Kuwata, K; Oya, K; Suganuma, M; Takahashi, T; Yamane, T | 1 |
| Kim, K; Liao, J; Yang, CS; Yang, GY; Yurkow, EJ | 1 |
| Naasani, I; Seimiya, H; Tsuruo, T | 1 |
| Fujiki, H; Ohkura, Y; Okabe, S; Suganuma, M | 1 |
| Bugianesi, R; Maiani, G; Salucci, M; Stivala, LA; Vannini, V | 1 |
3 review(s) available for catechin and Adenocarcinoma
| Article | Year |
|---|---|
Dietary agents for prevention and treatment of lung cancer.
Topics: Adenocarcinoma; Administration, Oral; Animals; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Catechin; Curcumin; Flavonoids; Flavonols; Humans; Indoles; Isothiocyanates; Lung Neoplasms; Plant Extracts; Polyphenols | 2015 |
The clusterin paradigm in prostate and breast carcinogenesis.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Apoptosis; Breast Neoplasms; Catechin; Cell Transformation, Neoplastic; Clusterin; Drug Resistance, Neoplasm; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Oncogenes; Orchiectomy; Prostatic Neoplasms; Protein Isoforms; Tumor Suppressor Proteins; Xenograft Model Antitumor Assays | 2010 |
Apoptosis by dietary agents for prevention and treatment of prostate cancer.
Topics: Adenocarcinoma; Aged; Animals; Apoptosis; Carotenoids; Catechin; Clinical Trials as Topic; Curcumin; Drug Screening Assays, Antitumor; Flavonoids; Flavonols; Genistein; Humans; Lycopene; Lythraceae; Male; Mice; Mice, Nude; Mice, Transgenic; Middle Aged; Neoplasm Proteins; Pentacyclic Triterpenes; Phytotherapy; Plant Extracts; Prostatic Neoplasms; Resveratrol; Stilbenes; Tumor Cells, Cultured | 2010 |
47 other study(ies) available for catechin and Adenocarcinoma
| Article | Year |
|---|---|
Characterization of procyanidin extracts from hawthorn (Crataegus pinnatifida) in human colorectal adenocarcinoma cell line Caco-2, simulated Digestion, and fermentation identified unique and novel prebiotic properties.
Topics: Adenocarcinoma; Caco-2 Cells; Catechin; Colorectal Neoplasms; Crataegus; Digestion; Fermentation; Humans; Proanthocyanidins | 2023 |
Apoptotic-Induced Effects of
Topics: Acacia; Adenocarcinoma; Animals; Apoptosis; Caspase 3; Caspase 9; Catechin; Cell Survival; Colonic Neoplasms; Dose-Response Relationship, Drug; HT29 Cells; Humans; Membrane Potential, Mitochondrial; Plant Extracts; Rats; Reactive Oxygen Species | 2020 |
Characterization of the cytotoxic effects of the combination of cisplatin and flavanol (-)-epicatechin on human lung cancer cell line A549. An isobolographic approach.
Topics: A549 Cells; Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Catechin; Cell Proliferation; Cell Survival; Cisplatin; Drug Synergism; Humans; Lung Neoplasms | 2018 |
Transport of Flavanolic Monomers and Procyanidin Dimer A2 across Human Adenocarcinoma Stomach Cells (MKN-28).
Topics: Adenocarcinoma; Biflavonoids; Biological Availability; Biological Transport; Catechin; Cell Line, Tumor; Chromatography, High Pressure Liquid; Dimerization; Flavanones; Fruit; Gastric Mucosa; Humans; Litchi; Plant Extracts; Proanthocyanidins | 2019 |
Cytotoxicity and apoptosis induction in human breast adenocarcinoma MCF-7 cells by (+)-cyanidan-3-ol.
Topics: Adenocarcinoma; Apoptosis; Breast Neoplasms; Catechin; Cell Proliferation; Cell Survival; DNA Fragmentation; Enzyme-Linked Immunosorbent Assay; Humans; MCF-7 Cells; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction | 2013 |
Enhancement of (-)-epigallocatechin-3-gallate and theaflavin-3-3'-digallate induced apoptosis by ascorbic acid in human lung adenocarcinoma SPC-A-1 cells and esophageal carcinoma Eca-109 cells via MAPK pathways.
Topics: Adenocarcinoma; Anticarcinogenic Agents; Antineoplastic Agents; Apoptosis; Ascorbic Acid; Biflavonoids; Caspase 3; Caspase 9; Catechin; Cell Line, Tumor; Enzyme Inhibitors; Esophageal Neoplasms; Gallic Acid; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; MAP Kinase Signaling System | 2013 |
Green tea phenolics inhibit butyrate-induced differentiation of colon cancer cells by interacting with monocarboxylate transporter 1.
Topics: Adenocarcinoma; Alkaline Phosphatase; Anticarcinogenic Agents; Apoptosis; Blotting, Western; Butyric Acid; Catechin; Cell Differentiation; Cell Membrane; Cell Proliferation; Colonic Neoplasms; Histamine Antagonists; Humans; Membrane Microdomains; Monocarboxylic Acid Transporters; Polyphenols; Tea; Tumor Cells, Cultured | 2013 |
Procyanidin induces apoptosis of esophageal adenocarcinoma cells via JNK activation of c-Jun.
Topics: Adenocarcinoma; Apoptosis; Biflavonoids; Caspase 3; Caspase 7; Catechin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Esophageal Neoplasms; Humans; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Phosphorylation; Proanthocyanidins; Promoter Regions, Genetic; Proto-Oncogene Proteins c-jun; Signal Transduction; Transcription Factor AP-1; Up-Regulation | 2014 |
Safety and chemopreventive effect of Polyphenon E in preventing early and metastatic progression of prostate cancer in TRAMP mice.
Topics: Adenocarcinoma; Animals; Catechin; Disease Models, Animal; Disease Progression; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Prostatic Neoplasms; Safety | 2014 |
Catechin-based procyanidins from Peumus boldus Mol. aqueous extract inhibit Helicobacter pylori urease and adherence to adenocarcinoma gastric cells.
Topics: Adenocarcinoma; Bacterial Adhesion; Biflavonoids; Catechin; Cell Line, Tumor; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Enzyme Inhibitors; Helicobacter pylori; Humans; Inhibitory Concentration 50; Microbial Sensitivity Tests; Peumus; Plant Extracts; Polyphenols; Proanthocyanidins; Urease | 2014 |
EGCG synergizes the therapeutic effect of cisplatin and oxaliplatin through autophagic pathway in human colorectal cancer cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Autophagy; Catechin; Cell Transformation, Neoplastic; Cisplatin; Colorectal Neoplasms; Drug Synergism; HT29 Cells; Humans; Microtubule-Associated Proteins; Organoplatinum Compounds; Oxaliplatin; Signal Transduction; Tea; Tumor Cells, Cultured | 2015 |
The up-regulation of Myb may help mediate EGCG inhibition effect on mouse lung adenocarcinoma.
Topics: Adenocarcinoma; Animals; Antioxidants; Catechin; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Kruppel-Like Transcription Factors; Lung; Lung Neoplasms; Mice, Inbred Strains; MicroRNAs; Proto-Oncogene Proteins c-myb; Up-Regulation | 2016 |
Green tea catechins suppress the DNA synthesis marker MCM7 in the TRAMP model of prostate cancer.
Topics: Adenocarcinoma; Animals; Biomarkers, Tumor; Catechin; Cell Cycle Proteins; DNA Replication; DNA-Binding Proteins; DNA, Neoplasm; Gene Expression Regulation, Neoplastic; Male; Mice; Mice, Transgenic; Minichromosome Maintenance Complex Component 7; Neoplasms, Experimental; Nuclear Proteins; Prostatic Neoplasms; Tea | 2007 |
The procyanidin-mediated induction of apoptosis and cell-cycle arrest in esophageal adenocarcinoma cells is not dependent on p21(Cip1/WAF1).
Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Apoptosis; Biflavonoids; Catechin; Cell Cycle; Cell Line, Tumor; Cell Survival; Cyclin-Dependent Kinase Inhibitor p21; Esophageal Neoplasms; Gene Expression Regulation, Neoplastic; Humans; Proanthocyanidins; RNA Interference; RNA, Messenger; RNA, Small Interfering; Time Factors; Up-Regulation | 2008 |
Procyanidin effects on oesophageal adenocarcinoma cells strongly depend on flavan-3-ol degree of polymerization.
Topics: Adenocarcinoma; Apoptosis; Biflavonoids; Catechin; Cell Cycle; Cell Line, Tumor; Cell Survival; Chromatography, High Pressure Liquid; Dimerization; Esophageal Neoplasms; Flavonoids; Humans; Malus; MAP Kinase Signaling System; Polymers; Proanthocyanidins | 2008 |
Polyphenon E inhibits the growth of human Barrett's and aerodigestive adenocarcinoma cells by suppressing cyclin D1 expression.
Topics: Adenocarcinoma; Antineoplastic Agents; Barrett Esophagus; Catechin; Cell Cycle; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cyclin D1; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; Phosphorylation; Proteasome Endopeptidase Complex; Tea | 2009 |
(-)-Epigallocatechin-3-gallate inhibits invasion and migration of salivary gland adenocarcinoma cells.
Topics: Adenocarcinoma; Anticarcinogenic Agents; Catechin; Cell Adhesion; Cell Movement; Cell Survival; Down-Regulation; Drug Evaluation, Preclinical; Gene Expression Regulation, Neoplastic; Humans; Integrin beta1; Matrix Metalloproteinases; Neoplasm Invasiveness; Salivary Gland Neoplasms; Tumor Cells, Cultured | 2010 |
Apoptotic effect of green tea polyphenol (EGCG) on cervical carcinoma cells.
Topics: Adenocarcinoma; Antioxidants; Apoptosis; Caspase 3; Catechin; Cell Line, Tumor; Drug Screening Assays, Antitumor; Female; Humans; Leukocytes, Mononuclear; Uterine Cervical Neoplasms | 2011 |
Chemopreventive effect of epigallocatechin-3-gallate (EGCG) and folic acid on the N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)-induced gastrointestinal cancer in rat model.
Topics: Adenocarcinoma; Administration, Oral; Animals; Anticarcinogenic Agents; Apoptosis; Catechin; Cell Proliferation; Disease Models, Animal; Drug Therapy, Combination; Folic Acid; Gastrointestinal Neoplasms; Hematinics; Male; Methylnitronitrosoguanidine; Rats; Rats, Wistar; Sarcoma; Treatment Outcome | 2011 |
EGCG downregulates IL-1RI expression and suppresses IL-1-induced tumorigenic factors in human pancreatic adenocarcinoma cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Catechin; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Humans; Interleukin-1; Matrix Metalloproteinase 2; Pancreatic Neoplasms; Receptors, Interleukin-1 Type I; Vascular Endothelial Growth Factor A | 2011 |
Chronic administration of green tea extract to TRAMP mice induces the collapse of Golgi apparatus in prostate secretory cells and results in alterations of protein post-translational processing.
Topics: Adenocarcinoma; Animals; Catechin; Clusterin; Disease Models, Animal; Endoplasmic Reticulum; Golgi Apparatus; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Prostatic Neoplasms; Protein Processing, Post-Translational; Tea | 2011 |
Adrenomedullin interacts with VEGF in endometrial cancer and has varied modulation in tumours of different grades.
Topics: Adenocarcinoma; Adrenomedullin; Biomarkers, Tumor; Case-Control Studies; Catechin; Cell Line, Tumor; Cobalt; Endometrial Neoplasms; Female; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Grading; Resveratrol; RNA, Messenger; Stilbenes; Up-Regulation; Vascular Endothelial Growth Factor A | 2012 |
(-)-Epigallocatechin-3-gallate, a green tea-derived catechin, synergizes with celecoxib to inhibit IL-1-induced tumorigenic mediators by human pancreatic adenocarcinoma cells Colo357.
Topics: Adenocarcinoma; Anticarcinogenic Agents; Camellia sinensis; Caspases; Catechin; Celecoxib; Cell Line, Tumor; Cyclooxygenase 2; Drug Synergism; Humans; Interleukin-1; Pancreatic Neoplasms; Pyrazoles; Sulfonamides | 2012 |
Different fatty acid metabolism effects of (-)-epigallocatechin-3-gallate and C75 in adenocarcinoma lung cancer.
Topics: 4-Butyrolactone; Adenocarcinoma; Adenocarcinoma of Lung; Analysis of Variance; Animals; Apoptosis; Carnitine O-Palmitoyltransferase; Catechin; Cell Line, Tumor; Fatty Acid Synthases; Fatty Acids; Female; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Phosphorylation; Random Allocation; Signal Transduction; Weight Loss; Xenograft Model Antitumor Assays | 2012 |
(-)-Epigallocatechin-3-gallate induces apoptosis in human endometrial adenocarcinoma cells via ROS generation and p38 MAP kinase activation.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Catechin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Down-Regulation; Endometrial Neoplasms; Female; Humans; p38 Mitogen-Activated Protein Kinases; Reactive Oxygen Species | 2013 |
(-)-Epigallocatechin 3-gallate inhibits invasion by inducing the expression of Raf kinase inhibitor protein in AsPC‑1 human pancreatic adenocarcinoma cells through the modulation of histone deacetylase activity.
Topics: Adenocarcinoma; Apoptosis; Blotting, Western; Cadherins; Catechin; Cell Movement; Cell Proliferation; Extracellular Signal-Regulated MAP Kinases; Histone Deacetylases; Humans; Matrix Metalloproteinase 2; Neoplasm Invasiveness; NF-kappa B; Pancreatic Neoplasms; Phosphatidylethanolamine Binding Protein; Phosphorylation; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Tumor Cells, Cultured | 2013 |
Effects of cacao liquor proanthocyanidins on PhIP-induced mutagenesis in vitro, and in vivo mammary and pancreatic tumorigenesis in female Sprague-Dawley rats.
Topics: Adenocarcinoma; Adenoma; Animals; Anthocyanins; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Biotransformation; Cacao; Carcinogens; Catechin; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Flavonoids; Imidazoles; Mammary Neoplasms, Experimental; Microsomes, Liver; Mutagenesis; Mutagenicity Tests; Organ Specificity; Pancreatic Neoplasms; Phenols; Phytotherapy; Plant Extracts; Polymers; Proanthocyanidins; Rats; Rats, Sprague-Dawley; Salmonella typhimurium | 2002 |
Resveratrol-induced modification of polyamine metabolism is accompanied by induction of c-Fos.
Topics: Acetyltransferases; Adenocarcinoma; Adenosylmethionine Decarboxylase; Anticarcinogenic Agents; Base Sequence; Caco-2 Cells; Catechin; Colonic Neoplasms; DNA Primers; Gene Expression Regulation; Humans; Ornithine Decarboxylase; Polyamines; Proto-Oncogene Proteins c-fos; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Stilbenes | 2003 |
Epigallocatechin-3-gallate-induced stress signals in HT-29 human colon adenocarcinoma cells.
Topics: Adenocarcinoma; Anticarcinogenic Agents; Antioxidants; Apoptosis; Blotting, Western; Caspase 3; Caspase 9; Caspases; Catalase; Catechin; Colonic Neoplasms; Cytochrome c Group; DNA, Neoplasm; Enzyme Activation; Enzyme Inhibitors; Free Radical Scavengers; Glutathione; HT29 Cells; Humans; JNK Mitogen-Activated Protein Kinases; Membrane Potentials; Mitochondria; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinases; Oxidants; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Urokinase-Type Plasminogen Activator | 2003 |
Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells.
Topics: Adenocarcinoma; Anticarcinogenic Agents; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Caspase 8; Caspase 9; Caspases; Catechin; Cell Division; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; DNA, Neoplasm; Enzyme Activation; Gene Expression Regulation, Neoplastic; Genes, bcl-2; Humans; Male; Neoplasm Proteins; NF-kappa B; Nuclear Proteins; Phosphorylation; Poly(ADP-ribose) Polymerases; Prostatic Neoplasms; Protein Processing, Post-Translational; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-mdm2; Signal Transduction; Transcription, Genetic; Tumor Cells, Cultured; Tumor Suppressor Protein p14ARF; Tumor Suppressor Protein p53 | 2003 |
Sulindac sulfide and caffeic acid phenethyl ester suppress the motility of lung adenocarcinoma cells promoted by transforming growth factor-beta through Akt inhibition.
Topics: Adenocarcinoma; Antineoplastic Agents; Caffeic Acids; Catechin; Cell Movement; Curcumin; Humans; Lung Neoplasms; Neovascularization, Pathologic; NF-kappa B; Phenylethyl Alcohol; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Sulindac; Transforming Growth Factor beta; Tumor Cells, Cultured | 2004 |
Prostate carcinoma and green tea: (-)epigallocatechin-3-gallate inhibits inflammation-triggered MMP-2 activation and invasion in murine TRAMP model.
Topics: Adenocarcinoma; Animals; Anticarcinogenic Agents; Catechin; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Inflammation; Male; Matrix Metalloproteinase 2; Mice; Neoplasm Invasiveness; Prostatic Neoplasms; Tea | 2004 |
Inhibitory effect of the tea polyphenol, (-)-epigallocatechin gallate, on growth of cervical adenocarcinoma cell lines.
Topics: Adenocarcinoma; Apoptosis; Catechin; Cell Line, Tumor; Cell Proliferation; Female; Flavonoids; Flow Cytometry; Humans; Ki-67 Antigen; Phenols; Polyphenols; Tea; Telomerase; Uterine Cervical Neoplasms | 2006 |
Effects of (-)epigallocatechin gallate and thymoquinone on proliferation of a PANC-1 cell line in culture.
Topics: Adenocarcinoma; Antineoplastic Agents; Antioxidants; Benzoquinones; Catechin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Humans; Pancreatic Neoplasms; Treatment Outcome | 2006 |
Constitutive overexpression of Nrf2-dependent heme oxygenase-1 in A549 cells contributes to resistance to apoptosis induced by epigallocatechin 3-gallate.
Topics: Adenocarcinoma; Antioxidants; Apoptosis; Catechin; Cell Line, Tumor; Cell Survival; Drug Resistance, Neoplasm; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Heme Oxygenase-1; Humans; Lung Neoplasms; NF-E2-Related Factor 2; Oxidation-Reduction; Protein Kinase C-alpha; Response Elements; RNA, Small Interfering; Sensitivity and Specificity; Transcriptional Activation | 2006 |
Inhibition of adenoma progression to adenocarcinoma in a 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis model in A/J mice by tea polyphenols and caffeine.
Topics: Adenocarcinoma; Adenoma; Analysis of Variance; Animals; Caffeine; Catechin; Cell Proliferation; Disease Progression; Female; Flavonoids; Immunohistochemistry; JNK Mitogen-Activated Protein Kinases; Lung; Lung Neoplasms; Mice; Mice, Inbred Strains; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Nitrosamines; Phenols; Phosphorylation; Polyphenols; Proliferating Cell Nuclear Antigen; Tea; Time Factors | 2006 |
A comparison of 5-fluorouracil and natural chemotherapeutic agents, EGCG and thymoquinone, delivered by sustained drug delivery on colon cancer cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Benzoquinones; Catechin; Cell Proliferation; Cell Survival; Colonic Neoplasms; Delayed-Action Preparations; Dose-Response Relationship, Drug; Fluorouracil; Humans; Phytotherapy; Plant Extracts; Treatment Outcome; Tumor Cells, Cultured | 2007 |
Epigenetic and genetic mechanisms contribute to telomerase inhibition by EGCG.
Topics: Adenocarcinoma; Apoptosis; Breast Neoplasms; Catechin; Cell Division; Cell Line, Tumor; DNA Methylation; E2F1 Transcription Factor; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Histones; HL-60 Cells; Humans; Lysine; Male; Methylation; Neoplasm Proteins; Promoter Regions, Genetic; Protein Processing, Post-Translational; RNA, Messenger; RNA, Neoplasm; Telomerase | 2008 |
Epigallocatechin-3-Gallate suppresses early stage, but not late stage prostate cancer in TRAMP mice: mechanisms of action.
Topics: Adenocarcinoma; Animals; Anticarcinogenic Agents; Apoptosis; Catechin; Cell Proliferation; Drug Screening Assays, Antitumor; Insulin-Like Growth Factor I; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Mice, Transgenic; Prostate; Prostatic Neoplasms; Receptor, IGF Type 1; Receptors, Androgen | 2007 |
Antiproliferative effects of the major tea polyphenol, (-)-epigallocatechin gallate and retinoic acid in cervical adenocarcinoma.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Caspase 3; Catechin; Cell Growth Processes; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Synergism; Female; HeLa Cells; Humans; Telomerase; Tretinoin; Uterine Cervical Neoplasms | 2008 |
Green tea polyphenol and epigallocatechin gallate induce apoptosis and inhibit invasion in human breast cancer cells.
Topics: Adenocarcinoma; Apoptosis; Apoptosis Regulatory Proteins; beta Catenin; Breast Neoplasms; Catechin; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Flavonoids; Gene Expression Regulation, Neoplastic; Humans; In Vitro Techniques; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Neoplasm Proteins; Oligonucleotide Array Sequence Analysis; Phenols; Phosphorylation; Polyphenols; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Tea | 2007 |
Involvement of 67-kDa laminin receptor-mediated myosin phosphatase activation in antiproliferative effect of epigallocatechin-3-O-gallate at a physiological concentration on Caco-2 colon cancer cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Caco-2 Cells; Catechin; Cell Cycle; Cell Proliferation; Colonic Neoplasms; HeLa Cells; Humans; Myosin-Light-Chain Phosphatase; Phosphorylation; Receptors, Laminin | 2008 |
Inhibition of N-methyl-N'-nitro-N-nitrosoguanidine-induced carcinogenesis by (-)-epigallocatechin gallate in the rat glandular stomach.
Topics: Adenocarcinoma; Adenoma; Animals; Antineoplastic Agents; Carcinoma, Papillary; Catechin; Drug Screening Assays, Antitumor; Male; Methylnitronitrosoguanidine; Ornithine Decarboxylase; Papilloma; Rats; Rats, Wistar; Stomach Neoplasms | 1995 |
Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols.
Topics: Adenocarcinoma; Anticarcinogenic Agents; Apoptosis; Catechin; Cell Division; Colonic Neoplasms; Humans; Lung Neoplasms; Superoxide Dismutase; Tea; Tumor Cells, Cultured | 1998 |
Telomerase inhibition, telomere shortening, and senescence of cancer cells by tea catechins.
Topics: Adenocarcinoma; Antineoplastic Agents; beta-Galactosidase; Catechin; Cell-Free System; Cellular Senescence; Colonic Neoplasms; Enzyme Inhibitors; Humans; Kinetics; Leukemia, Monocytic, Acute; Neoplasms; Tea; Telomerase; Telomere; Tumor Cells, Cultured | 1998 |
Combination cancer chemoprevention with green tea extract and sulindac shown in intestinal tumor formation in Min mice.
Topics: Adenocarcinoma; Animals; Catechin; Intestinal Neoplasms; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Plant Extracts; Sulindac; Tea | 2001 |
Flavonoids uptake and their effect on cell cycle of human colon adenocarcinoma cells (Caco2).
Topics: Adenocarcinoma; Anticarcinogenic Agents; Antioxidants; Catechin; Cell Cycle; Cell Division; Colonic Neoplasms; Flavonoids; Gallic Acid; Humans; Hydrogen Peroxide; Molecular Structure; Quercetin; Structure-Activity Relationship; Tea; Tumor Cells, Cultured | 2002 |